1 |
Dwivedi S, Choudhary P, Gupta A, Singh S. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Crit Rev Microbiol 2022;:1-16. [PMID: 35324372 DOI: 10.1080/1040841X.2022.2052795] [Reference Citation Analysis]
|
2 |
Ahmadikia K, Hashemi SJ, Khodavaisy S, Getso MI, Alijani N, Badali H, Mirhendi H, Salehi M, Tabari A, Mohammadi Ardehali M, Kord M, Roilides E, Rezaie S. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses 2021;64:798-808. [PMID: 33590551 DOI: 10.1111/myc.13256] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
|
3 |
Ma X, Zhang S, Xing H, Li H, Chen J, Li H, Jiao M, Shi Q, Xu A, Xing L, Cao W. Invasive Pulmonary Aspergillosis Diagnosis via Peripheral Blood Metagenomic Next-Generation Sequencing. Front Med 2022;9:751617. [DOI: 10.3389/fmed.2022.751617] [Reference Citation Analysis]
|
4 |
Salehi M, Ghaderkhani S, Sharifian RA, Dehghan Manshadi SA, Samiee Fard E, Khodavaisy S, Pourahmad R, Foroushani AR, Rodini K, Kamali Sarvestani H. The Value of Nasal and Oral Clinical Examination in Febrile Neutropenic Patients for Initiating Antifungal Therapy as a Preemptive Method. Front Med 2022;8:803600. [DOI: 10.3389/fmed.2021.803600] [Reference Citation Analysis]
|
5 |
Sharmin S, Rahaman MM, Sarkar C, Atolani O, Islam MT, Adeyemi OS. Nanoparticles as antimicrobial and antiviral agents: A literature-based perspective study. Heliyon 2021;7:e06456. [PMID: 33763612 DOI: 10.1016/j.heliyon.2021.e06456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|